WHO ICTRP trial
EUCTR2017-002780-17-FR · NeuroDerm Ltd.
EUCTR2017-002780-17-FR · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2017-002780-17-FR |
|---|---|
| Scientific title | A Pivotal, Open-Label, Randomized, Crossover, Four Sequences Study in Male and Female Patients with Advanced Parkinson’s Disease to Assess the Relative Bioavailability of Levodopa Administered as ND0612 Subcutaneous Infusion via a Pump System plus Additional Oral Administered Levodopa/Carbidopa… |
| Primary sponsor | NeuroDerm Ltd. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | United States;France;Spain;Austria;Netherlands;Italy |
| Conditions | Parkinson’s Disease MedDRA version: 20.0 Level: HLT Classification code 10034005 Term: Parkinson's disease and parkinsonism System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10] |
| Interventions | Product Name: ND0612 Product Code: ND0612 Pharmaceutical Form: Solution for infusion in administration system INN or Proposed INN: carbidopa CAS Number: 38821-49-7 Current Sponsor code: - Other descriptive name: CARBIDOPA Concentration… |
| Registration date | Feb 27, 2018 |
| Target size | 50 |
| Secondary IDs | ND0612-315;2017-002780-17-ES |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: